Xenon Pharmaceuticals Inc (XENE)
39.79
-0.55
(-1.36%)
USD |
NASDAQ |
May 17, 16:00
39.79
0.00 (0.00%)
Pre-Market: 20:00
Xenon Pharmaceuticals Cash and Short Term Investments (Quarterly): 699.60M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 699.60M |
December 31, 2023 | 638.08M |
September 30, 2023 | 526.67M |
June 30, 2023 | 539.60M |
March 31, 2023 | 527.04M |
December 31, 2022 | 592.09M |
September 30, 2022 | 638.18M |
June 30, 2022 | 788.24M |
March 31, 2022 | 537.94M |
December 31, 2021 | 551.77M |
September 30, 2021 | 249.62M |
June 30, 2021 | 260.52M |
March 31, 2021 | 274.70M |
December 31, 2020 | 177.00M |
September 30, 2020 | 190.93M |
June 30, 2020 | 202.75M |
March 31, 2020 | 229.67M |
December 31, 2019 | 141.36M |
September 30, 2019 | 94.60M |
June 30, 2019 | 101.80M |
March 31, 2019 | 110.43M |
Date | Value |
---|---|
December 31, 2018 | 119.31M |
September 30, 2018 | 127.13M |
June 30, 2018 | 63.27M |
March 31, 2018 | 35.08M |
December 31, 2017 | 43.67M |
September 30, 2017 | 43.77M |
June 30, 2017 | 51.70M |
March 31, 2017 | 58.03M |
December 31, 2016 | 64.15M |
September 30, 2016 | 69.49M |
June 30, 2016 | 50.74M |
March 31, 2016 | 56.06M |
December 31, 2015 | 58.65M |
September 30, 2015 | 65.47M |
June 30, 2015 | 73.70M |
March 31, 2015 | 75.38M |
December 31, 2014 | 84.04M |
September 30, 2014 | 47.94M |
June 30, 2014 | 44.71M |
December 31, 2013 | 49.28M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
94.60M
Minimum
Sep 2019
788.24M
Maximum
Jun 2022
398.11M
Average
400.69M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Acasti Pharma Inc | 25.11M |
Aurinia Pharmaceuticals Inc | 350.49M |
Edesa Biotech Inc | 2.800M |
Lexaria Bioscience Corp | 4.793M |
ESSA Pharma Inc | 135.89M |